X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.pharmatimes.com/news/european_commission_approves_cystic_fibrosis_treatment_for_six_to_11-year-olds_1386105
https://www.biospace.com/article/releases/vertex-announces-fda-approvals-of-trikafta-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-symdeko-tezacaftor-ivacaftor-and-ivacaftor-and-kalydeco-ivacaftor-for-use-in-people-with-cf-with-certain-rare-mutations/?s=74
http://www.pharmatimes.com/news/symkevikalydeco_cleared_for_use_in_young_cf_patients_1358460
https://www.businesswire.com/news/home/20200924005175/en/Vertex-to-Present-New-Data-at-European-and-North-American-Virtual-Cystic-Fibrosis-Conferences-Highlighting-Long-Term-Use-of-CFTR-Modulators
https://icer-review.org/announcements/icer-issues-final-report-and-policy-recommendations-on-treatments-for-cystic-fibrosis/
https://www.ema.europa.eu/en/documents/overview/kaftrio-epar-medicine-overview_en.pdf
https://www.europeanpharmaceuticalreview.com/news/126549/vertexs-kaftrio-approved-for-use-in-europe-and-made-accessible-on-the-nhs/
http://www.pharmatimes.com/news/eu_nod_for_vertex_cf_therapy_kaftrio_1347238
http://www.pharmatimes.com/news/vertex_and_nhs_wales_agree_on_kaftrio_reimbursement_1345325
https://via.tt.se/pressmeddelande/vertex-announces-expansion-of-reimbursement-agreement-with-nhs-england-to-include-kaftrio-ivacaftortezacaftorelexacaftor-in-combination-with-kalydeco-ivacaftor?publisherId=259167&releaseId=3279501#:~:text=Vertex%20Pharmaceuticals%20Incorporated%20(Nasdaq%3A%20VRTX,mg%2C%20ahead%20of%20the%20medicine's
https://www.fiercepharma.com/pharma/even-amid-a-pandemic-vertex-raises-guidance-thanks-to-gangbusters-start-for-trikafta
https://endpts.com/vertexs-cystic-fibrosis-drugs-work-but-theyre-too-expensive-icer-finds/
https://www.fiercepharma.com/pharma/as-trikafta-launch-got-underway-vertex-s-leiden-scored-18-79m-final-full-year-as-ceo
https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-innovative-reimbursement-agreement-switzerland
https://www.biopharmadive.com/news/vertex-trikafta-launch-cystic-fibrosis-leiden/571452/
https://www.reuters.com/article/us-britain-cystic-fibrosis-drug/vertex-deal-with-wales-expands-cystic-fibrosis-treatment-coverage-to-all-of-uk-idUSKBN1XN1IK
https://www.fiercepharma.com/pharma/vertex-s-triple-combo-launch-trikafta-underway-as-drugmaker-humming-analyst-says
https://www.fiercepharma.com/pharma/vertex-s-triple-combo-launch-trikafta-underway-as-drugmaker-humming-analyst-says
https://www.fiercepharma.com/pharma/vertex-lands-blockbuster-triple-combo-nod-for-cf-drug-trikafta-5-months-early
https://www.fda.gov/news-events/press-announcements/fda-approves-new-breakthrough-therapy-cystic-fibrosis
https://www.forbes.com/sites/danadovey/2019/10/22/fda-approves-cystic-fibrosis-drug-applicable-for-90-percent-of-patients/#23a9b1be5cd2
https://www.raps.org/regulatory-focus/news-articles/2017/12/regulatory-explainer-everything-you-need-to-know-about-fdas-priority-review-vouchers
https://pharmaphorum.com/news/scotlands-cost-regulator-rejects-vertex-cystic-fibrosis-drugs/
https://pharmaphorum.com/news/vertex-chief-leiden-to-step-down-with-cmo-named-successor/
https://www.prnewswire.com/news-releases/fda-expands-approval-of-treatment-for-cystic-fibrosis-to-include-patients-ages-6-and-older-300872824.html
http://www.pmlive.com/pharma_news/vertex_makes_choice_for_all-important_cf_triple_therapy_1289543
https://www.fiercepharma.com/pharma/vertex-chief-leiden-snags-9-pay-raise-to-18-8m-extraordinary-2018
https://www.reuters.com/article/us-vertex-pharms-study/vertex-cystic-fibrosis-triple-combo-therapy-succeeds-in-important-trials-idUSKCN1QN1LI
http://www.pmlive.com/pharma_news/vertex_an_extreme_outlier_in_pricing_and_behaviour,_says_nhs_england_1276896
Market Place
Share 
